Loading...
XTAI
1720
Market cap343mUSD
Aug 01, Last price  
57.40TWD
1D
0.00%
1Q
-2.71%
Jan 2017
76.07%
Name

Standard Chem & Pharm Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
11.65
P/S
1.51
EPS
4.93
Div Yield, %
4.70%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
11.51%
Revenues
6.79b
+8.81%
1,924,414,0002,011,721,0002,182,198,0002,284,616,0002,894,482,0003,332,008,0003,373,811,0003,053,983,0003,295,656,0003,321,366,0003,673,801,0003,848,684,0003,573,093,0003,937,129,0004,305,400,0004,604,082,0005,851,368,0006,239,768,0006,789,223,000
Net income
881m
+5.46%
323,443,000267,715,000274,597,000293,463,000210,053,000246,748,000271,426,000298,386,000374,235,000347,894,000340,216,000363,286,000374,359,000376,482,000524,172,000706,734,0001,153,620,000834,886,000880,501,000
CFO
1.69b
+26.82%
358,745,000323,595,000719,169,000634,227,000272,474,000405,494,000402,246,000427,259,000582,305,000650,865,000305,376,000708,738,000484,935,000637,939,000922,580,000827,034,0001,227,834,0001,336,523,0001,694,941,000
Dividend
Aug 01, 20242.7 TWD/sh

Profile

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.
URL
https://www.standard.com.tw/
IPO date
Dec 12, 1995
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,789,223
8.81%
6,239,768
6.64%
5,851,368
27.09%
Cost of revenue
5,381,384
4,989,283
4,715,135
Unusual Expense (Income)
NOPBT
1,407,839
1,250,485
1,136,233
NOPBT Margin
20.74%
20.04%
19.42%
Operating Taxes
333,049
279,938
246,313
Tax Rate
23.66%
22.39%
21.68%
NOPAT
1,074,790
970,547
889,920
Net income
880,501
5.46%
834,886
-27.63%
1,153,620
63.23%
Dividends
(482,479)
(446,740)
(446,740)
Dividend yield
4.37%
3.79%
4.06%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
553,547
883,193
1,829,066
Long-term debt
595,102
690,579
676,597
Deferred revenue
Other long-term liabilities
85,404
235,814
149,464
Net debt
(1,579,440)
(1,669,493)
(598,169)
Cash flow
Cash from operating activities
1,694,941
1,336,523
1,227,834
CAPEX
(594,139)
(625,696)
(1,197,542)
Cash from investing activities
(771,692)
(653,125)
(1,080,831)
Cash from financing activities
(1,444,306)
(957,365)
(465,444)
FCF
496,699
769,849
(304,781)
Balance
Cash
1,811,988
2,275,533
2,599,039
Long term investments
916,101
967,732
504,793
Excess cash
2,388,628
2,931,277
2,811,264
Stockholders' equity
7,603,557
8,908,165
7,215,530
Invested Capital
7,594,038
6,769,760
6,799,525
ROIC
14.97%
14.31%
14.23%
ROCE
13.98%
12.89%
11.72%
EV
Common stock shares outstanding
178,192
178,890
178,885
Price
61.90
-6.07%
65.90
7.15%
61.50
42.69%
Market cap
11,030,073
-6.44%
11,788,851
7.16%
11,001,428
42.67%
EV
12,521,686
12,957,679
13,085,686
EBITDA
1,812,577
1,598,258
1,434,838
EV/EBITDA
6.91
8.11
9.12
Interest
15,069
25,793
18,775
Interest/NOPBT
1.07%
2.06%
1.65%